Product information
From Health Canada
No match found
No other product was found with the same active ingredient group.
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Approved
Current status date:
2022-07-06
Product name:
SANDOZ TACROLIMUS XR
DIN:
02528614
Product Monograph/Veterinary Labelling:
Date:
2023-06-21
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
SANDOZ CANADA INCORPORATED
110 Rue De Lauzon
Boucherville
Quebec
Canada
J4B 1E6
Class:
Human
Dosage form(s):
Capsule (Extended Release)
Route(s) of administration:
Oral
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
92:44.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
L04AD02 TACROLIMUS
Active ingredient group (AIG) number:See footnote5
0127857009
| Active ingredient(s) See footnote8 | Strength |
|---|---|
| TACROLIMUS | 2 MG |